331 related articles for article (PubMed ID: 26344767)
1. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
[TBL] [Abstract][Full Text] [Related]
2. [Novel function of MeCP2 in the pathophysiology of Rett syndrome: Regulation of mTOR signaling mediated by MeCP2-dependent microRNA processing].
Tsujimura K; Nakashima K
Seikagaku; 2017 Feb; 89(1):51-61. PubMed ID: 29624958
[No Abstract] [Full Text] [Related]
3. MeCP2 controls neural stem cell fate specification through miR-199a-mediated inhibition of BMP-Smad signaling.
Nakashima H; Tsujimura K; Irie K; Imamura T; Trujillo CA; Ishizu M; Uesaka M; Pan M; Noguchi H; Okada K; Aoyagi K; Andoh-Noda T; Okano H; Muotri AR; Nakashima K
Cell Rep; 2021 May; 35(7):109124. PubMed ID: 34010654
[TBL] [Abstract][Full Text] [Related]
4. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.
Ricciardi S; Boggio EM; Grosso S; Lonetti G; Forlani G; Stefanelli G; Calcagno E; Morello N; Landsberger N; Biffo S; Pizzorusso T; Giustetto M; Broccoli V
Hum Mol Genet; 2011 Mar; 20(6):1182-96. PubMed ID: 21212100
[TBL] [Abstract][Full Text] [Related]
5. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.
Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M
Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102
[TBL] [Abstract][Full Text] [Related]
6. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
[TBL] [Abstract][Full Text] [Related]
7. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
8. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
9. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
Bissonnette JM; Knopp SJ
Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521
[TBL] [Abstract][Full Text] [Related]
10. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder.
Liao W; Gandal MJ; Ehrlichman RS; Siegel SJ; Carlson GC
Neurobiol Dis; 2012 Apr; 46(1):88-92. PubMed ID: 22249109
[TBL] [Abstract][Full Text] [Related]
11. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex.
Cheng TL; Wang Z; Liao Q; Zhu Y; Zhou WH; Xu W; Qiu Z
Dev Cell; 2014 Mar; 28(5):547-60. PubMed ID: 24636259
[TBL] [Abstract][Full Text] [Related]
12. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
13. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
[TBL] [Abstract][Full Text] [Related]
14. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome.
Wu H; Tao J; Chen PJ; Shahab A; Ge W; Hart RP; Ruan X; Ruan Y; Sun YE
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18161-6. PubMed ID: 20921386
[TBL] [Abstract][Full Text] [Related]
17. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.
Urdinguio RG; Fernandez AF; Lopez-Nieva P; Rossi S; Huertas D; Kulis M; Liu CG; Croce CM; Calin GA; Esteller M
Epigenetics; 2010 Oct; 5(7):656-63. PubMed ID: 20716963
[TBL] [Abstract][Full Text] [Related]
18. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
19. Reduction of aberrant NF-κB signalling ameliorates Rett syndrome phenotypes in Mecp2-null mice.
Kishi N; MacDonald JL; Ye J; Molyneaux BJ; Azim E; Macklis JD
Nat Commun; 2016 Jan; 7():10520. PubMed ID: 26821816
[TBL] [Abstract][Full Text] [Related]
20. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
